📖
Sodium Glucose Cotransporter 2 Inhibitor Use in Diabetic Patients With Cirrhosis Improves Liver-Related Outcomes and Survival.
Jalil S, Bari K, Mumtaz K, Ibrahim A, Bhatti TK, Pothuraju S, Adam M, Magon HS, Duong N, Kwo PY

Sodium Glucose Cotransporter 2 Inhibitor Use in Diabetic Patients With Cirrhosis Improves Liver-Related Outcomes and Survival.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Clin Transl Gastroenterol.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Sodium Glucose Cotransporter 2 Inhibitor Use in Diabetic Patients With Cirrhosis Improves Liver-Related Outcomes and Survival.
Author / Organization Jalil S, Bari K, Mumtaz K, Ibrahim A, Bhatti TK, Pothuraju S, Adam M, Magon HS, Duong N, Kwo PY
Subject & Discipline Clin Transl Gastroenterol
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-44347
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »